Preclinical Evaluation of an Imidazole-Linked Heterocycle for Alzheimer's Disease.

MLA

Bagán, Andrea, et al. “Preclinical Evaluation of an Imidazole-Linked Heterocycle for Alzheimer’s Disease.” Pharmaceutics, vol. 15, no. 10, Oct. 2023, p. 2381. EBSCOhost, https://doi.org/10.3390/pharmaceutics15102381.

APA

Bagán, A., Rodriguez-Arévalo, S., Taboada-Jara, T., Griñán-Ferré, C., Pallàs, M., Brocos-Mosquera, I., Callado, L. F., Morales-García, J. A., Pérez, B., Diaz, C., Fernández-Godino, R., Genilloud, O., Beljkas, M., Oljacic, S., Nikolic, K., & Escolano, C. (2023). Preclinical Evaluation of an Imidazole-Linked Heterocycle for Alzheimer’s Disease. Pharmaceutics, 15(10), 2381. https://doi.org/10.3390/pharmaceutics15102381

Chicago

Bagán, Andrea, Sergio Rodriguez-Arévalo, Teresa Taboada-Jara, Christian Griñán-Ferré, Mercè Pallàs, Iria Brocos-Mosquera, Luis F. Callado, et al. 2023. “Preclinical Evaluation of an Imidazole-Linked Heterocycle for Alzheimer’s Disease.” Pharmaceutics 15 (10): 2381. doi:10.3390/pharmaceutics15102381.